BCV vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BCV exhibits a stable financial profile with a Piotroski F-Score of 6/9 and an exceptionally strong value proposition. The stock is trading at a massive discount to its Graham Number ($64.45) and Intrinsic Value ($217.41), supported by an incredibly low P/E ratio of 3.24 and a Price/Book of 0.95. While technical trends are currently bearish and revenue growth is slightly negative, the explosive earnings growth (432.40% YoY) and high ROE (27.25%) suggest a highly efficient operation. The dividend is well-covered with a low payout ratio of 17.37%, making this a compelling deep-value play.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BCV vs BRK-B: Head-to-Head Comparison
This page compares Bancroft Fund Ltd. (BCV) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.